| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6235169e1642cae3b1417c6add7bda0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_370ceef221c99ef934a2ac8d55ecba7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa2eb8e207c9e0d73684ffa985ffc051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70557 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2012-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf97ac070327c8009087e02ad811b99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971f313041a7588695c7ca3425cc82c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564d6564cfa79d78871cac07601f48fb |
| publicationDate |
2012-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012167028-A2 |
| titleOfInvention |
Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition |
| abstract |
In alternative embodiments, the invention provides compositions and methods for identifying individuals that would be responsive to a treatment comprising (including) blocking activation of integrin polypeptide alphav-beta3 (or αν-β3), or blocking the interaction of a ligand with integrin polypeptide alphav-beta3 (or αν-β3). The invention provides compositions and methods for determining the effectiveness of such a treatment and can contribute to a prognosis for the patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10435472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3285876-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016041614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016041616-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106714835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11306146-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107973852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021278416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11415581-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015039020-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107073111-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020512978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105906692-A |
| priorityDate |
2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |